• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Hemolink对肠道运动功能的影响以及特定药物对这些影响的减弱作用。

Hemolink-induced effects on intestinal motor function and attenuation of these effects by selected agents.

作者信息

Wong L T, Er S S, Ning J, Christoff B, Carmichael F J

机构信息

Hemosol Inc., Etobicoke, Ontario, Canada.

出版信息

Artif Cells Blood Substit Immobil Biotechnol. 1998 Nov;26(5-6):529-48. doi: 10.3109/10731199809117473.

DOI:10.3109/10731199809117473
PMID:9844719
Abstract

Hemolink, an oxidized, ring-opened raffinose-crosslinked hemoglobin-based oxygen carrier produced by Hemosol Inc., stimulates esophageal peristalsis, possibly by interference with neural NO-mediated effects. The effects of Hemolink on jejunal tone and contractions, arterial pressure and heart rate were measured in anesthetized rats, and the effect of selected agents in attenuating or reversing these effects was studied. Infusion of L-NAME was used to validate the study model; it caused an immediate increase in tone and initiated phasic contractions indicating that the model was responsive to NO-mediated effects. Hemolink administration caused effects on intestinal motor function similar to those caused by L-NAME, including increases in basal tone and contraction amplitude. Rat whole blood caused none of these changes. The Hemolink-induced effects were less immediate in some animals compared to those observed after L-NAME. As well there was greater inter-animal variability on the effects. Hemolink administration also caused a mild increase in arterial blood pressure and a reciprocal decrease in heart rate in some animals. Co-administration of morphine, a common analgesic that has been reported to influence the motility of the GI tract; L-arginine, a substrate for NO synthesis; and glycopyrrolate, an anti-cholinergic agent, did not significantly modulate the Hemolink effects, whereas nitroglycerin, an NO donor; and nifedipine, a slow calcium-channel blocker, attenuated or reversed these effects.

摘要

Hemolink是由Hemosol公司生产的一种基于氧化、开环棉子糖交联血红蛋白的氧载体,它可能通过干扰神经一氧化氮介导的效应来刺激食管蠕动。在麻醉大鼠中测量了Hemolink对空肠张力和收缩、动脉血压和心率的影响,并研究了选定药物减弱或逆转这些影响的作用。输注L-精氨酸甲酯(L-NAME)用于验证研究模型;它导致张力立即增加并引发相性收缩,表明该模型对一氧化氮介导的效应有反应。给予Hemolink对肠道运动功能产生的影响与给予L-NAME所产生的影响相似,包括基础张力和收缩幅度增加。大鼠全血未引起这些变化。与给予L-NAME后观察到的情况相比,Hemolink诱导的效应在一些动物中不太迅速。而且动物之间的效应变异性更大。给予Hemolink还导致一些动物的动脉血压轻度升高,心率相应降低。同时给予吗啡(一种据报道会影响胃肠道运动的常用镇痛药)、L-精氨酸(一氧化氮合成的底物)和格隆溴铵(一种抗胆碱能药物),并未显著调节Hemolink的效应,而一氧化氮供体硝酸甘油和慢钙通道阻滞剂硝苯地平减弱或逆转了这些效应。

相似文献

1
Hemolink-induced effects on intestinal motor function and attenuation of these effects by selected agents.Hemolink对肠道运动功能的影响以及特定药物对这些影响的减弱作用。
Artif Cells Blood Substit Immobil Biotechnol. 1998 Nov;26(5-6):529-48. doi: 10.3109/10731199809117473.
2
A phase I study of oxidized raffinose cross-linked human hemoglobin.氧化棉子糖交联人血红蛋白的I期研究。
Crit Care Med. 2000 Jul;28(7):2283-92. doi: 10.1097/00003246-200007000-00017.
3
The effects of hemodilution with Hemolink upon hemodynamics and blood flow distribution in anesthetized dogs.
Artif Cells Blood Substit Immobil Biotechnol. 2001 Nov;29(6):465-81. doi: 10.1081/bio-100108551.
4
L-NAME, nitric oxide and jejunal motility, blood flow and oxygen uptake in dogs.左旋精氨酸甲酯、一氧化氮与犬空肠运动、血流及氧摄取
Br J Pharmacol. 1994 Jan;111(1):205-12. doi: 10.1111/j.1476-5381.1994.tb14045.x.
5
The effects of hemodilution with Hemolink upon hemodynamics and blood flow distribution in anesthetized dogs.Hemolink血液稀释对麻醉犬血流动力学和血流分布的影响。
Artif Cells Blood Substit Immobil Biotechnol. 2002 Mar;30(2):137-54. doi: 10.1081/bio-120003194.
6
Involvement of endogenous nitric oxide in the regulation of rat intestinal motility in vivo.内源性一氧化氮参与大鼠体内肠道运动的调节。
Eur J Pharmacol. 1992 Dec 15;229(2-3):273-6. doi: 10.1016/0014-2999(92)90567-n.
7
Human haemoglobin--hemosol: hemolink.
BioDrugs. 2002;16(3):223-5. doi: 10.2165/00063030-200216030-00009.
8
Hemolink, an o-raffinose cross-linked haemoglobin-based oxygen carrier, does not affect activation and function of human platelets in whole blood in vitro.Hemolink是一种基于低聚果糖交联血红蛋白的氧载体,在体外不影响全血中人类血小板的激活和功能。
Br J Haematol. 2003 Feb;120(3):535-41. doi: 10.1046/j.1365-2141.2003.04068.x.
9
A comparison of the acute hemodynamic and delayed effects of 50% exchange transfusion with two different cross-linked hemoglobin based oxygen carrying solutions and Pentastarch.50%换血疗法与两种不同的基于交联血红蛋白的携氧溶液及羟乙基淀粉的急性血流动力学和延迟效应比较。
Artif Cells Blood Substit Immobil Biotechnol. 2006;34(2):145-57. doi: 10.1080/10731190600580215.
10
Interferences of o-raffinose cross-linked hemoglobin in three methods for serum creatinine.棉子糖交联血红蛋白对三种血清肌酐检测方法的干扰
Clin Chem. 1997 Sep;43(9):1738-43.